Autologous stem cell transplantation as rescue therapy in malignant forms of multiple sclerosis

Abstract

Malignant forms of multiple sclerosis (MS) represent a limited group of very aggressive demyelinating diseases, which rapidly progress to severe disability leading often to life-threatening conditions. On these clinical entities, currently available therapies for MS are not very effective. Recently, it has been demonstrated that intense immunosuppression followed by autologous stem cell transplantation (ASCT) can affect the clinical course of individuals with severe MS and completely abrogate the inflammatory activity detected by magnetic resonance imaging (MRI). We report on the treatment with intense immune ablation followed by ASCT of three patients with malignant MS whose clinical course indicated a dramatically poor prognosis. This procedure succeeded in halting the rapidly worsening course of disease. The effect was long lasting, as demonstrated by a sustained efficacy over a two-year period in two subjects and 12 months in the third case. In addition, a striking effect on inflammation-related MRI findings was obtained. These results support a role for intense immunosuppression followed by ASCT as treatment in rapidly evolving malignant MS cases unresponsive to conventional therapies.

Keywords

autologous stem cells transplantation immunosuppression MS

Get full access to this article

View all access options for this article.

References

Matthews WB. Clinical aspects. Course and prognosis. In Matthews WB ed. McAlpine’s multiple sclerosis, second edition. Edinburgh, UK: Churchill Livingstone , 1991: 139-163.

Rodriguez M , Karnes WE , Bartleson JD , Pineda AA. Plasma-pheresis in acute episodes of fulminant CNS inflammatory demyelination . Neurology 1993; 43: 1100-1104 .

Jacquerye P , Ossemann M , Laloux P , Dive A , De Coene B. Acute fulminant multiple sclerosis and plasma exchange . Eur Neurol 1999; 41: 174-175 .

Youl BD , Kermode AG , Thompson AJ , Revesz T , Scaravilli F , Barnard RO et al. Destructive lesions in demyelinating disease . J Neurol Neurosurg Psychiatry 1991; 54: 288-292 .

Monaca C , Stoijkovic T , de Seze J , Ruchoux MM , Pruvo JP , Vermersch P. Fulminant multiple sclerosis . Rev Neurol 2000; 156: 180-181 .

Fassas A , Anagnostopoulos A , Kazis A , Kapinas K , Sakellari I , Kimiskidis V et al. Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study . Bone Marrow Transplant 1997; 20: 631-638 .

Burt RK , Traynor AE , Cohen B , Karlin KH , Davis FA , Stefoski D et al. T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients . Bone Marrow Transplant 1998; 21: 537-541 .

Kozak T , Havrdova E , Pit’ha J , Gregora E , Pytlik R , Maaloufova J et al. High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis . Bone Marrow Transplant 2000; 25: 525-531 .

Openshaw H , Lund BT , Kashyap A , Atkinson R , Sniecinski I , Weiner LP et al. Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring . Biol Blood Marrow Transplant 2000; 6: 563-575 .

10.

Fassas A , Anagnostopoulos A , Kazis A , Kapinas K , Sakellari I , Kimiskidis V et al. Autologous stem cell transplantation in progressive multiple sclerosis-an interim analysis of efficacy . J Clin Immunol 2000; 20: 24-30 .

11.

Saiz A , Carreras E , Berenguer J , Yague J , Martinez C , Marin P et al. MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS . Neurology 2001; 56: 1084-1089 .

12.

Mancardi GL , Saccardi R , Filippi M , Gualandi F , Murialdo A , Inglese M et al. Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS . Neurology 2001; 57: 62-68 .

13.

Burt RK , Cohen BA , Russell E , Spero K , Joshi A , Oyama Y et al. Hematopoietic stem cell transplantation for progressive multiple sclerosis: failure of a total body irradiation-based conditioning regimen to prevent disease progression in patients with high disability scores . Blood 2003; 102: 2373-2378 .

14.

Nash RA , Bowen JD , McSweeney PA , Pavletic SZ , Maravilla KR , Park MS et al. High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis . Blood 2003; 102: 2364-2372 .

15.

Carreras E , Saiz A , Marin P , Martinez C , Rovira M , Villamor N et al. CD34+ selected autologous peripheral blood stem cell transplantation for multiple sclerosis: report of toxicity and treatment results at one year of follow-up in 15 patients . Haematologica 2003; 88: 306-314 .

16.

Saccardi R , Mancardi GL , Solari A , Bosi A , Bruzzi P , Di Bartolomeo P et al. Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life . Blood 2005; 105: 2601-2607 .

17.

Antin JH , Ferrara JL. Cytokine dysregulation and acute graft-versus-host disease . Blood 1992; 80: 2964-2968 .

18.

Prineas JW , McDonald WI. Demyelinating diseases. In Graham DI , Lantos PL eds. Greenfield’s neuropathology, sixth edition. London, New York: Arnold , 1997: 813-896.

19.

Marburg O. Die sogenannte akute multiple sklerose (encephalomyelitis periaxialis scleroticans) . Jahrb Psychiatr Neurol 1906; 27: 213-311 .

20.

Poser S , Luer W , Bruhn H , Frahm J , Bruck Y , Felgenhauer K. Acute demyelinating disease. Classification and non-invasive diagnosis . Acta Neurol Scand 1992; 86: 579-585 .

21.

Wood DD , Bilbao JM , O’Connors P , Moscarello MA. Acute multiple sclerosis (Marburg type) is associated with developmentally immature myelin basic protein . Ann Neurol 1996; 40: 18-24 .

22.

Balò J. Encephalitis periaxialis concentrica . Arch Neurol Psychiatry 1928; 19: 242-264 .

23.

Schilder P. Zur Kenntnis der sogenannten diffusen Sklerose . Z Ges Neurol Psichiatr 1912; 10: 1-60 .

24.

Devic E. Mielite subaigue compliquée de nevrite optique . Bull Med 1894; 8: 1033-1034 .

25.

Leonardi A , Arata L , Farinelli M , Cocito L , Schenone A , Tabaton M et al. Fluid and neuropathological study in Devic’s syndrome. Evidence of intrathecal immune activation . J Neurol Sci 1987; 82: 281-290 .

26.

de Seze J. Neuromyelitis optica . Arch Neurol 2003; 60: 1336-1338 .

27.

Lennon VA , Wingerchuk DM , Kryzer TJ , Pittock SJ , Lucchinetti CF , Fujihara K et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis . Lancet 2004; 364: 2106-2112 .

28.

Bitsch A , Wegener C , da Costa C , Bunkowski S , Reimers CD , Prange HW et al. Lesion development in Marburg’s type of acute multiple sclerosis: from inflammation to demyelination . Mult Scler 1999; 5: 138-146 .

29.

Fassas A , Passweg JR , Anagnostopoulos A , Kazis A , Kozak T , Havrdova E et al. Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study . J Neurol 2002; 249: 1088-1097 .